Author

Marina Flotats‐Bastardas

Observed names: Flotats Bastardas, Marina, Flotats-Bastardas M, Flotats-Bastardas, Marina, M. Flotats-Bastardas, Marina Flotats Bastardas, Marina Flotats- Bastardas, Marina Flotats-Bastardas, Marina Flotats-Bastardes, Marina FlotatsBastardas, Marina Flotats‑Bastardas

Institution: Saarland University

Observed institutions: Universitat Autònoma de Barcelona, Witten/Herdecke University, Universitätsklinikum des Saarlandes, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Klinikum Kassel, Saarland University

ORCID: 0000-0001-7696-4808

Observed ORCID: 0000-0001-7696-4808

OpenAlex ID: A5005494473

Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis

2021 · Franziska S. Thaler, Luise Zimmermann, et al. · Neurology Neuroimmunology & Neuroinflammation · 196

Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study

2018 · Daniel Ebrahimi-Fakhari, Lilian Lisa Mann, et al. · Orphanet Journal of Rare Diseases · 181

Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease

2022 · Thomas Grüter, Franziska E Möllers, et al. · Brain · 124

Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy

2022 · Astrid Pechmann, Max Behrens, et al. · Brain · 77

Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy

2024 · Oliver Schwartz, Katharina Vill, et al. · Archives of Pediatrics and Adolescent Medicine · 74

CSF Findings in Acute NMDAR and LGI1 Antibody–Associated Autoimmune Encephalitis

2021 · Marc Dürr, Gunnar Nissen, et al. · Neurology Neuroimmunology & Neuroinflammation · 72

Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study

2024 · René Günther, Claudia Diana Wurster, et al. · The Lancet Regional Health - Europe · 65

A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies

2022 · Christine Strippel, Marisol Herrera-Rivero, et al. · Brain · 46

A loss-of-function CACNA1A mutation causing benign paroxysmal torticollis of infancy

2014 · Marta Vila-Pueyo, Gemma G. Gené, et al. · European Journal of Paediatric Neurology · 43

Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study

2022 · Astrid Pechmann, Max Behrens, et al. · Orphanet Journal of Rare Diseases · 41

Newbornscreening SMA – From Pilot Project to Nationwide Screening in Germany

2022 · Wolfgang Müller-Felber, Astrid Blaschek, et al. · Journal of Neuromuscular Diseases · 40

Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis

2021 · Anja K. Tietz, Klemens Angstwurm, et al. · Neurology Neuroimmunology & Neuroinflammation · 35

Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study

2024 · Claudia Weiß, Lena-Luise Becker, et al. · The Lancet Regional Health - Europe · 32

Off-Label Use of Ataluren in Four Non-ambulatory Patients With Duchenne Muscular Dystrophy: Effects on Cardiac and Pulmonary Function and Muscle Strength

2018 · Daniel Ebrahimi-Fakhari, Ulrich Dillmann, et al. · Frontiers in Pediatrics · 31

Improvements in Walking Distance during Nusinersen Treatment – A Prospective 3-year SMArtCARE Registry Study

2022 · Astrid Pechmann, Max Behrens, et al. · Journal of Neuromuscular Diseases · 30

Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders and Parental Stress: Findings from a National, Prospective TSC Surveillance Study

2019 · Daniel Ebrahimi-Fakhari, Justine Hussong, et al. · Neuropediatrics · 22

5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2

2024 · Katharina Vill, Moritz Tacke, et al. · Journal of Neurology · 21

New Therapeutics Options for Pediatric Neuromuscular Disorders

2020 · Marina Flotats-Bastardas, Andreas Hahn · Frontiers in Pediatrics · 17

Topical Rapamycin for Facial Angiofibromas in a Child with Tuberous Sclerosis Complex (TSC): A Case Report and Long-Term Follow-up

2017 · Daniel Ebrahimi-Fakhari, Cornelia Sigrid Lissi Müller, et al. · Dermatology and Therapy · 17

Treatment with Nusinersen – Challenges Regarding the Indication for Children with SMA Type 1

2019 · Astrid Pechmann, Matthias Baumann, et al. · Journal of Neuromuscular Diseases · 16

Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease

2025 · Thomas Grüter, Carles Gaig, et al. · JAMA Neurology · 14

Different pain phenotypes are associated with anti-Caspr2 autoantibodies

2024 · Patrik Greguletz, Maria Plötz, et al. · Journal of Neurology · 14

Mitochondrial diseases mimicking autoimmune diseases of the CNS and good response to steroids initially

2022 · Adela Della Marina, Annikki Bertolini, et al. · European Journal of Paediatric Neurology · 14

Multicenter Experience with Nusinersen Application via an Intrathecal Port and Catheter System in Spinal Muscular Atrophy

2020 · Marina Flotats-Bastardas, Andreas Hahn, et al. · Neuropediatrics · 14

Assessment of Inadequate Use of Pediatric Emergency Medical Transport Services: The Pediatric Emergency and Ambulance Critical Evaluation (PEACE) Study

2019 · Martin Poryo, Martin Burger, et al. · Frontiers in Pediatrics · 14

Works count: 91

Citation count: 1,413

H-index: 17

I10-index: 31